Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
Metropolis Healthcare Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Metropolis Healthcare wird ein jährliches Gewinn- und Umsatzwachstum von 23.9% bzw. 11% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 23.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 19.8% betragen.
Wichtige Informationen
23.9%
Wachstumsrate der Gewinne
23.5%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 25.7% |
| Wachstumsrate der Einnahmen | 11.0% |
| Zukünftige Eigenkapitalrendite | 19.8% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 28 May 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next
May 24
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E
Mar 28Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal
Jan 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion
Dec 23Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?
Sep 08Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital
Jun 20Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively
Mar 14Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00
Feb 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price
Sep 25Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?
Sep 10Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet
Jun 07Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
May 16Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?
Mar 17Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
Jan 29Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?
Dec 14Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns
Oct 12Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?
Aug 27Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean
Jul 06I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease
May 28Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns
Mar 29Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?
Mar 11Trade Alert: The Chief Executive Officer Of Metropolis Healthcare Limited (NSE:METROPOLIS), Vijender Singh, Has Sold Some Shares Recently
Feb 24Metropolis Healthcare Limited (NSE:METROPOLIS) Passed Our Checks, And It's About To Pay A ₹8.00 Dividend
Feb 12Metropolis Healthcare Limited's (NSE:METROPOLIS) 0.4% Dividend Yield Looks Pretty Interesting
Feb 09
Is Metropolis Healthcare Limited (NSE:METROPOLIS) Popular Amongst Insiders?
Jan 25Is Metropolis Healthcare Limited's (NSE:METROPOLIS) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jan 10Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 3/31/2027 | 17,240 | 2,691 | 3,368 | 3,831 | 8 |
| 3/31/2026 | 15,394 | 2,266 | 2,935 | 3,259 | 15 |
| 3/31/2025 | 13,602 | 1,771 | 2,303 | 2,936 | 15 |
| 3/31/2024 | 12,077 | 1,278 | 2,003 | 2,641 | N/A |
| 12/31/2023 | 11,593 | 1,248 | N/A | N/A | N/A |
| 9/30/2023 | 11,536 | 1,334 | 1,718 | 2,183 | N/A |
| 6/30/2023 | 11,454 | 1,383 | N/A | N/A | N/A |
| 3/31/2023 | 11,482 | 1,429 | 1,945 | 2,471 | N/A |
| 12/31/2022 | 11,716 | 1,495 | N/A | N/A | N/A |
| 9/30/2022 | 11,792 | 1,548 | 1,754 | 2,266 | N/A |
| 6/30/2022 | 11,814 | 1,727 | N/A | N/A | N/A |
| 3/31/2022 | 12,283 | 2,142 | 2,226 | 2,533 | N/A |
| 12/31/2021 | 12,142 | 2,355 | N/A | N/A | N/A |
| 9/30/2021 | 11,959 | 2,531 | 2,924 | 3,195 | N/A |
| 6/30/2021 | 11,816 | 2,551 | N/A | N/A | N/A |
| 3/31/2021 | 9,980 | 1,831 | 2,208 | 2,490 | N/A |
| 12/31/2020 | 9,132 | 1,372 | N/A | N/A | N/A |
| 9/30/2020 | 8,613 | 1,207 | 1,756 | 2,059 | N/A |
| 6/30/2020 | 7,962 | 1,034 | N/A | N/A | N/A |
| 3/31/2020 | 8,564 | 1,273 | 1,788 | 2,150 | N/A |
| 12/31/2019 | 8,513 | 1,463 | N/A | N/A | N/A |
| 9/30/2019 | 8,189 | 1,355 | 1,020 | 1,341 | N/A |
| 6/30/2019 | 7,887 | 1,230 | N/A | N/A | N/A |
| 3/31/2019 | 7,612 | 1,201 | 664 | 902 | N/A |
| 3/31/2018 | 6,472 | 1,042 | 840 | 1,039 | N/A |
| 3/31/2017 | 5,447 | 1,017 | N/A | 1,018 | N/A |
| 3/31/2016 | 4,755 | 768 | N/A | 914 | N/A |
| 3/31/2015 | 4,555 | 610 | N/A | 695 | N/A |
| 3/31/2014 | 3,883 | 566 | N/A | 769 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: METROPOLISDas prognostizierte Gewinnwachstum (23.9% pro Jahr) liegt über der Sparquote (6.7%).
Ertrag vs. Markt: METROPOLISDie Erträge des Unternehmens (23.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (16% pro Jahr).
Hohe Wachstumserträge: METROPOLISEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: METROPOLISDie Einnahmen des Unternehmens (11% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (9.4% pro Jahr).
Hohe Wachstumseinnahmen: METROPOLISDie Einnahmen des Unternehmens (11% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: METROPOLISDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (19.8 %).